Table 4 |
||
|
Likelihood of a negative test for claims indicating hyponatremia* |
||
|
OR |
95% CI |
|
|
|
||
|
Age in years |
0.97 |
0.96, 0.97 |
|
Female |
0.75 |
0.67, 0.85 |
|
Underlying conditions and comorbidities |
||
|
Cerebrovascular disease |
0.61 |
0.50, 0.73 |
|
Chronic obstructive pulmonary disease |
0.62 |
0.54, 0.72 |
|
Congestive heart failure |
1.09 |
0.89, 1.34 |
|
Coronary heart disease |
0.98 |
0.84, 1.14 |
|
Dementia |
0.44 |
0.27, 0.70 |
|
Diabetes mellitus |
1.47 |
1.27, 1.70 |
|
Hypertension |
0.53 |
0.47, 0.59 |
|
Kidney disease |
1.24 |
0.84, 1.83 |
|
Liver cirrhosis†|
0.31 |
0.07, 1.38 |
|
Metastatic carcinoma |
1.11 |
0.87, 1.41 |
|
Nephritis, nephrotic syndrome, and nephrosis |
0.49 |
0.35, 0.69 |
|
Peripheral vascular disease |
1.40 |
1.08, 1.82 |
|
Rheumatic disease |
1.27 |
0.91, 1.77 |
|
Syndrome of inappropriate antidiuretic hormone |
0.06 |
0.04, 0.08 |
|
Medications known to cause hyponatremia |
1.08 |
0.95, 1.22 |
|
|
||
|
* Hyponatremia was defined as serum sodium < 136 mmol/L. A negative test was defined as the presence of an outpatient professional claim with no ICD-9-CM code for hyponatremia or the absence of any outpatient professional claims within 15 days before or after the laboratory claim indicating hyponatremia. †Indicates that the condition was present in < 1% of the population. Abbreviations: OR indicates odds ratio; and CI, confidence interval. |
||
|
Shea et al. BMC Nephrology 2008 9:5 doi:10.1186/1471-2369-9-5 |
||